Yifeng Nie

Statistics

Publications

Citations

159

H-Index

Active since

2025

Affiliations

National Center for Nanoscience and Technology(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Shanghai University of Traditional Chinese Medicine

Guang’anmen Hospital

Shuguang Hospital

Yifeng Nie is an author at National Center for Nanoscience and Technology specializing in anthracycline-induced cardiotoxicity, chemotherapy, and molecular pharmacology.

Publications per year

2025–2025

Publications

Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance

Junyan Wang, Haowen Zhuang, Chun Li et al. · Journal of Nanobiotechnology · 2025 · 101 citations · Full text

Medicine, Cardiology, Pharmacology +16

A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5–DUSP1 axis for mitochondrial repair

Hongshuo Shi, Boxian Pang, Fenglei Zhang et al. · Journal of Nanobiotechnology · 2025 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Burden of respiratory tract cancers in China and its provinces, 1990–2021: a systematic analysis of the Global Burden of Disease Study 2021

Xiaozhu Liu, Qizhi Yang, Liming Pan et al. · The Lancet Regional Health - Western Pacific · 2025 · 11 citations · Full text

Medicine, Health Sciences, Oncology +17

1–3 of 3